Staff Profile: Christine M. Cutillo

Christine M. Cutillo, M.M.C.i.

Data Science Lead

Office of the Director

National Center for Advancing Translational Sciences

National Institutes of Health

Email Christine M. Cutillo


Christine Cutillo is the data science lead in the Office of the Director at NCATS. In that capacity, she works with Offices and Divisions across NCATS to strategically plan and drive successful operations of data science activities at the Center.

Cutillo joined NCATS in 2012 as a scientific program management analyst in the Division of Preclinical Innovation, working on grant coordination and submissions, education and outreach, and reporting of scientific projects and activities. She became special assistant to the director in late 2012 and worked on collaborative initiatives to advance translational science, particularly data-driven projects in the areas of rare disease and artificial/machine intelligence, international efforts to advance the science and understanding of biomedical translation through global cooperation and collaborative projects, and education-related resources to increase the awareness and understanding of translational science. Prior to joining NCATS, she worked for four years at the National Human Genome Research Institute, tracking and evaluating the progress of the Large-Scale Genome Sequencing Centers, in addition to working with extramural teams to manage four other programs.

Cutillo holds a bachelor’s degree in biology and math from Georgetown University, a Master of Management in Clinical Informatics from the Duke University School of Medicine, and a certificate in project management from Georgetown University.

Professional Interests

Cutillo is highly interested in data-driven scientific and health care innovations that are transparent, ethical and designed for and with the patient.

Selected Publications

  1. Machine Intelligence in Healthcare-Perspectives on Trustworthiness, Explainability, Usability, and Transparency
  2. International Collaborative Actions and Transparency to Understand, Diagnose, and Develop Therapies for Rare Diseases
  3. Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective
  4. Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective
  5. A Global Approach to Rare Diseases Research and Orphan Products Development: The International Rare Diseases Research Consortium (IRDiRC)